
About Indo Amines
Indo Amines is a publicly listed company based in Thane (India) founded in 1994. Aliphatic and aromatic amines are manufactured by Indo Amines. The company has 609 employees. Indo Amines has completed 1 acquisition, including Key Organics. Its chief executive, as recorded, is Vijay Palkar. Its Indian entity Indo Amines Limited reported revenue of βΉ1,188 Cr. Indo Amines offers products and services including Fine Chemicals and Specialty Chemicals. Its focus areas include Chemicals and Materials and Flavors and Fragrances.
Company details
Indo Amines was established in 1994 in Thane, India, within the chemical sector. Aliphatic and aromatic amines are produced by the company as its primary operations. Focus is placed on manufacturing these compounds for various industrial applications. Leadership is provided by CEO and MD Vijay Palkar. Activities are centered in India, supporting the specialty chemicals domain through consistent production processes.
- Headquarters Thane, India
- Employees 609
- Stage Public
- SectorsChemicals & Materials
- Website indoaminesltd.com
- Social LinkedIn X YouTube
- Legal Name Indo Amines Limited
- Market Cap₹834 Cr
INDOAMIN · NSE
- Share Price₹115.89
+0.81% today
- Revenue₹1,160 Cr
FY 2025-26 · +7.5% YoY
- EBITDA₹123 Cr
Margin 10.6%
- Net Profit₹79.32 Cr
FY 2025-26 · +43.5% YoY
- P/E (TTM)10.9x
P/B 2.3x
- Employee Count609
- Investments & Acquisitions
Associated legal entities of Indo Amines
Indo Amines operates through Indo Amines Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Indo Amines Limited Listed CIN L99999MH1992PLC070022 | Active | 17 Dec 1992 | Thane, Maharashtra | ₹1,188 Cr | 558 | 21 | View details |
Products & Services of Indo Amines
Indo Amines offers a comprehensive portfolio of products and services, including Fine Chemicals and Specialty Chemicals.
Fine chemicals are manufactured for applications in pharmaceuticals and other sectors
Specialty chemicals are produced for use in agrochemicals and performance industries
Apps and channels of Indo Amines
its YouTube channel Indo Amines has 59 subscribers and 2 videos.
Videos from Indo Amines
The most watched videos on Indo Amines's YouTube channel, Indo Amines (59 subscribers). Click a video to play it here.
More on Indo Amines.
Board of directors of Indo Amines Limited (Indo Amines)
Indo Amines Limited is the primary company behind Indo Amines. The board of Indo Amines Limited currently have 17 directors; the longest-serving is Rahul Vijay Palkar, appointed in 1994. 24 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rahul Vijay Palkar DIN 00325590 | Managing Director | 19 Feb 1994 | 32 yrs 8 mo | Indo Amines Limited |
| Vijay Bhalchandra Palkar DIN 00136027 | Managing Director | 01 Apr 2008 | 18 yrs 7 mo | Indo Amines Limited |
| Tripti Mahesh Sharma DIN 09570188 | Company Secretary | 15 Feb 2016 | 10 yrs 8 mo | Indo Amines Limited |
| Satish Madhukar Chitale DIN 08149259 | Director | 30 May 2018 | 8 yrs 5 mo | Indo Amines Limited |
| Jayaprakash Anand Shetty DIN 07980763 | Whole-time director | 25 Sep 2018 | 8 yrs 1 mo | Indo Amines Limited |
| Bharati Vijay Palkar DIN 00136185 | Whole-time director | 20 Jul 2020 | 6 yrs 3 mo | Indo Amines Limited |
| Adhikrao Abaji Shingade DIN 09219226 | Whole-time director | 28 Jun 2021 | 5 yrs 4 mo | Indo Amines Limited |
| Pradeep Hari Thakur DIN 00685992 | Director | 25 Feb 2022 | 4 yrs 8 mo | Indo Amines Limited |
| Rohan Rajeev Deshpande DIN 09520645 | Director | 25 Feb 2022 | 4 yrs 8 mo | Indo Amines Limited |
| Ajay Marathe DIN 09522762 | Director | 28 Feb 2022 | 4 yrs 8 mo | Indo Amines Limited |
| Vijay Yeshwant Sane DIN 10153927 | Director | 09 May 2023 | 3 yrs 6 mo | Indo Amines Limited |
| Avinash Krishna Aphale DIN 10167429 | Director | 18 May 2023 | 3 yrs 5 mo | Indo Amines Limited |
| Dhawal Jitendra Vora DIN 00130115 | Director | 10 Aug 2023 | 3 yrs 3 mo | Indo Amines Limited |
| Suniti Sagar Thombre DIN 09518356 | CFO | 10 Nov 2023 | 2 yrs 11 mo | Indo Amines Limited |
| Saji Jose DIN 10650311 | Whole-time director | 01 Jun 2024 | 2 yrs 5 mo | Indo Amines Limited |
| Tejaswini Shirish Dalvi DIN 11127538 | Director | 29 May 2025 | 1 yr 5 mo | Indo Amines Limited |
| Rahul Sharad Chitnis DIN 06634770 | Additional Director | 15 Jul 2026 | 3 mo | Indo Amines Limited |
People of Indo Amines
12 people are tracked at Indo Amines (9 in leadership, 3 in team); the tracked headcount is 609.
| Name | Role | Group |
|---|---|---|
| CEO & MD | Leadership | |
| Joint Managing Director | Leadership | |
Vijay Naik | Executive Director | Leadership |
Amol Bhopte | Deputy General Manager | Leadership |
| Non-executive Director | Leadership | |
| Executive Director | Leadership | |
Deepak Kanekar | Chairman & Non-executive Director | Leadership |
| Executive Director | Leadership | |
Prasad Taranekar | Vice President Sales Marketing | Leadership |
Hemant Mistry | Senior Production Executive | Team |
Ashwin Vs | Senior Business Development Executive | Team |
Swapnil Hande | Manager Maintenance And Project | Team |
Complete people profiles for Indo Amines
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Indo Amines
Indo Amines is a publicly listed company on the NSE with ticker symbol INDOAMIN in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date29 Apr 2022
- Listed onNSE: INDOAMIN
- Listed entityIndo Amines Limited
- Exchange sectorProcess industries
- ISININE760F01028
- Share price₹152.30 (-1.56% on the day) · 2026-10-14
- Market capitalisation₹1,122 Cr
- Price to earnings13.6
- EPS (diluted, trailing year)₹11.19
- Dividend yield0.32%
- Volume (last session)207,354
Financials of Indo Amines
Exchange-reported figures of Indo Amines Limited, the listed company behind Indo Amines (NSE: INDOAMIN).
Financial Highlights
FY 2025-26 Β· ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 1,160 | 1,079 | 943 | 945 | 786 | 541 | 479 |
| Revenue growth | +7.5% | +14.3% | -0.2% | +20.2% | +45.4% | +12.9% | - |
| EBITDA | 123 | 101 | 80.10 | 87.12 | 52.22 | 61.33 | 42.14 |
| EBITDA margin | +10.6% | +9.4% | +8.5% | +9.2% | +6.6% | +11.4% | +8.8% |
| Profit before tax | 106 | 76.96 | 58.27 | 56.80 | 34.52 | 48.99 | 18.34 |
| Net profit | 79.32 | 55.27 | 41.02 | 40.42 | 22.77 | 37.42 | 12.80 |
| Net profit margin | +6.8% | +5.1% | +4.4% | +4.3% | +2.9% | +6.9% | +2.7% |
| EPS (βΉ) | 10.79 | 7.61 | 5.89 | 5.72 | 3.23 | 10.64 | 3.84 |
| Balance sheet | |||||||
| Total assets | 707 | 605 | 483 | 459 | 397 | 323 | 280 |
| Net worth | 392 | 317 | 264 | 225 | 188 | 163 | 135 |
| Total debt | 311 | 284 | 217 | 232 | 207 | 159 | 143 |
| Cash & bank | 22.23 | 15.15 | 20.51 | 18.26 | 23.69 | 15.16 | 9.76 |
| Net working capital | 347 | 296 | 248 | 237 | 183 | 134 | 130 |
| Cash flow | |||||||
| Cash from operations | 78.80 | 35.40 | 69.89 | 20.36 | 15.46 | 56.18 | 38.75 |
| Cash from investing | (70.56) | (82.36) | (26.76) | (29.83) | (38.84) | (49.66) | (36.05) |
| Cash from financing | (1.16) | 41.60 | (40.87) | 4.03 | 31.92 | (1.12) | (2.67) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 375 | 318 | 277 | 277 | 288 | 285 | 259 | 269 |
| Revenue growth (YoY) | +30.3% | +11.3% | +7.2% | +2.9% | +8.6% | - | - | - |
| Other income | 1.44 | 5.90 | 2.24 | 4.91 | 15.52 | 0.28 | 2.39 | 5.29 |
| EBITDA | 52.80 | 34.23 | 25.26 | 31.97 | 31.32 | 24.81 | 24.41 | 24.03 |
| EBITDA margin | +14.1% | +10.8% | +9.1% | +11.5% | +10.9% | +8.7% | +9.4% | +8.9% |
| Depreciation | 6.32 | 5.79 | 5.40 | 5.23 | 5.08 | 4.18 | 4.34 | 4.34 |
| Interest | 6.25 | 5.66 | 5.82 | 6.06 | 6.20 | 5.67 | 5.70 | 5.56 |
| Profit before tax | 41.67 | 28.68 | 16.28 | 25.59 | 35.56 | 15.24 | 16.76 | 19.42 |
| Tax | 10.93 | 8.17 | 4.42 | 7.48 | 6.71 | 3.39 | 5.46 | 5.63 |
| Net profit | 30.74 | 20.51 | 11.86 | 18.11 | 28.85 | 11.85 | 11.30 | 13.79 |
| EPS (βΉ) | 4.19 | 2.73 | 1.62 | 2.50 | 3.94 | 1.68 | 1.55 | 1.91 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 1,118 | 1,057 | 925 | 922 | 780 | 539 | 472 |
| Revenue growth | +5.8% | +14.2% | +0.3% | +18.2% | +44.7% | +14.2% | - |
| EBITDA | 121 | 105 | 81.18 | 83.13 | 52.59 | 56.08 | 42.36 |
| EBITDA margin | +10.8% | +10.0% | +8.8% | +9.0% | +6.7% | +10.4% | +9.0% |
| Profit before tax | 105 | 81.88 | 59.54 | 52.63 | 35.18 | 43.07 | 18.67 |
| Net profit | 79.77 | 61.41 | 42.80 | 38.00 | 24.87 | 32.80 | 13.77 |
| Net profit margin | +7.1% | +5.8% | +4.6% | +4.1% | +3.2% | +6.1% | +2.9% |
| EPS (βΉ) | 10.85 | 8.46 | 6.13 | 5.37 | 3.52 | 9.33 | 4.14 |
| Balance sheet | |||||||
| Total assets | 699 | 599 | 471 | 449 | 391 | 320 | 277 |
| Net worth | 390 | 315 | 258 | 217 | 183 | 161 | 132 |
| Total debt | 306 | 280 | 212 | 230 | 206 | 158 | 142 |
| Cash & bank | 16.16 | 12.25 | 14.62 | 13.23 | 18.92 | 11.12 | 5.34 |
| Net working capital | 347 | 297 | 242 | 231 | 180 | 132 | 128 |
| Cash flow | |||||||
| Cash from operations | 73.13 | 38.63 | 69.46 | 19.17 | (7.43) | 53.27 | 37.48 |
| Cash from investing | (68.50) | (83.92) | (24.59) | (28.06) | (36.17) | (49.89) | (35.04) |
| Cash from financing | (0.72) | 42.91 | (43.74) | 3.20 | 51.40 | 2.40 | (3.65) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 367 | 311 | 269 | 267 | 271 | 278 | 256 | 268 |
| Revenue growth (YoY) | +35.6% | +11.7% | +4.8% | -0.4% | +7.1% | - | - | - |
| Other income | 1.44 | 5.82 | 2.31 | 4.76 | 15.56 | 0.42 | 2.26 | 5.26 |
| Total expenses | 315 | 277 | 243 | 233 | 244 | 255 | 227 | 242 |
| EBITDA | 51.83 | 33.96 | 25.74 | 34.13 | 27.36 | 23.58 | 29.20 | 25.99 |
| EBITDA margin | +14.1% | +10.9% | +9.6% | +12.8% | +10.1% | +8.5% | +11.4% | +9.7% |
| Depreciation | 6.14 | 5.65 | 5.27 | 5.10 | 4.96 | 4.06 | 4.25 | 4.20 |
| Interest | 6.09 | 5.53 | 5.68 | 5.92 | 6.06 | 5.56 | 5.51 | 5.41 |
| Profit before tax | 41.04 | 28.60 | 17.10 | 27.87 | 31.90 | 14.38 | 21.70 | 21.64 |
| Tax | 10.41 | 7.82 | 4.24 | 7.25 | 6.42 | 3.39 | 5.38 | 5.51 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 375 | 318 | 277 | 277 | 288 | 285 | 259 | 269 |
| Revenue growth (YoY) | +30.3% | +11.3% | +7.2% | +2.9% | +8.6% | - | - | - |
| Other income | 1.44 | 5.90 | 2.24 | 4.91 | 15.52 | 0.28 | 2.39 | 5.29 |
| EBITDA | 52.80 | 34.23 | 25.26 | 31.97 | 31.32 | 24.81 | 24.41 | 24.03 |
| EBITDA margin | +14.1% | +10.8% | +9.1% | +11.5% | +10.9% | +8.7% | +9.4% | +8.9% |
| Depreciation | 6.32 | 5.79 | 5.40 | 5.23 | 5.08 | 4.18 | 4.34 | 4.34 |
| Interest | 6.25 | 5.66 | 5.82 | 6.06 | 6.20 | 5.67 | 5.70 | 5.56 |
| Profit before tax | 41.67 | 28.68 | 16.28 | 25.59 | 35.56 | 15.24 | 16.76 | 19.42 |
| Tax | 10.93 | 8.17 | 4.42 | 7.48 | 6.71 | 3.39 | 5.46 | 5.63 |
| Net profit | 30.74 | 20.51 | 11.86 | 18.11 | 28.85 | 11.85 | 11.30 | 13.79 |
| EPS (βΉ) | 4.19 | 2.73 | 1.62 | 2.50 | 3.94 | 1.68 | 1.55 | 1.91 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,160 | 1,079 | 943 | 945 | 786 | 541 | 479 |
| Revenue growth | +7.5% | +14.3% | -0.2% | +20.2% | +45.4% | +12.9% | - |
| Other income | 28.57 | 15.15 | 15.70 | 4.23 | 10.36 | 8.06 | 6.58 |
| Total expenses | 1,037 | 978 | 863 | 858 | 734 | 479 | 437 |
| Employee cost | 0.00 | 50.60 | 39.61 | 32.62 | 27.57 | 23.87 | 23.82 |
| EBITDA | 123 | 101 | 80.10 | 87.12 | 52.22 | 61.33 | 42.14 |
| EBITDA margin | +10.6% | +9.4% | +8.5% | +9.2% | +6.6% | +11.4% | +8.8% |
| Depreciation | 21.49 | 17.04 | 15.27 | 17.31 | 14.09 | 11.18 | 19.52 |
| Interest | 23.74 | 22.30 | 22.26 | 17.24 | 13.97 | 9.22 | 10.86 |
| Profit before tax | 106 | 76.96 | 58.27 | 56.80 | 34.52 | 48.99 | 18.34 |
| Tax | 26.79 | 21.05 | 15.29 | 15.91 | 11.47 | 11.45 | 5.52 |
| Net profit | 79.32 | 55.27 | 41.02 | 40.42 | 22.77 | 37.42 | 12.80 |
| Net profit margin | +6.8% | +5.1% | +4.4% | +4.3% | +2.9% | +6.9% | +2.7% |
| EPS (βΉ) | 10.79 | 7.61 | 5.89 | 5.72 | 3.23 | 10.64 | 3.84 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 36.29 | 36.29 | 36.29 | 35.35 | 35.35 | 35.35 | 33.35 |
| Reserves & surplus | 356 | 281 | 228 | 190 | 152 | 127 | 99.51 |
| Shareholders' funds (net worth) | 392 | 317 | 264 | 225 | 188 | 163 | 135 |
| Minority interest | 1.43 | 0.65 | 0.24 | 0.44 | 0.21 | (0.37) | (0.56) |
| Secured loans | 305 | 283 | 217 | 232 | 207 | 159 | 142 |
| Unsecured loans | 5.86 | 1.85 | 0.01 | 0.00 | 0.62 | 0.06 | 0.75 |
| Total debt | 311 | 284 | 217 | 232 | 207 | 159 | 143 |
| Total liabilities | 707 | 605 | 483 | 459 | 397 | 323 | 280 |
| Assets | |||||||
| Gross block | 514 | 436 | 383 | 357 | 324 | 253 | 234 |
| Net block | 325 | 265 | 209 | 198 | 182 | 125 | 117 |
| Capital work in progress | 31.30 | 35.09 | 22.58 | 20.50 | 22.46 | 54.27 | 23.73 |
| Investments | 2.72 | 2.87 | 2.35 | 0.36 | 0.09 | 0.09 | 0.09 |
| Inventories | 178 | 140 | 114 | 136 | 123 | 87.84 | 81.78 |
| Sundry debtors | 282 | 255 | 218 | 187 | 167 | 131 | 95.77 |
| Cash & bank balances | 22.23 | 15.15 | 20.51 | 18.26 | 23.69 | 15.16 | 9.76 |
| Loans & advances | 46.42 | 53.04 | 41.96 | 31.17 | 26.71 | 30.21 | 24.01 |
| Total current assets | 528 | 463 | 394 | 373 | 340 | 265 | 211 |
| Total current liabilities | 181 | 167 | 146 | 135 | 158 | 130 | 81.19 |
| Net working capital | 347 | 296 | 248 | 237 | 183 | 134 | 130 |
| Total assets | 707 | 605 | 483 | 459 | 397 | 323 | 280 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 15.15 | 20.51 | 18.26 | 23.69 | 15.16 | 9.76 | 9.74 |
| Net cash from operating activities | 78.80 | 35.40 | 69.89 | 20.36 | 15.46 | 56.18 | 38.75 |
| Net cash from investing activities | (70.56) | (82.36) | (26.76) | (29.83) | (38.84) | (49.66) | (36.05) |
| Net cash from financing activities | (1.16) | 41.60 | (40.87) | 4.03 | 31.92 | (1.12) | (2.67) |
| Net change in cash | 7.08 | (5.36) | 2.26 | (5.44) | 8.53 | 5.40 | 0.03 |
| Closing cash | 22.23 | 15.15 | 20.51 | 18.26 | 23.69 | 15.16 | 9.76 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +7.5% | +14.3% | -0.2% | +20.2% | +45.4% | +12.9% | - |
| EBITDA growth | +21.4% | +26.3% | -8.1% | +66.8% | -14.9% | +45.5% | - |
| PBT growth | +37.9% | +32.1% | +2.6% | +64.5% | -29.5% | +167.1% | -51.7% |
| Net income growth | +43.5% | +34.7% | +1.5% | +77.5% | -39.2% | +192.3% | - |
| Revenue CAGR (3Y) | +7.1% | +11.1% | +20.4% | +25.4% | +14.2% | +15.0% | +18.9% |
| EBITDA CAGR (3Y) | +12.1% | +24.7% | +9.3% | +27.4% | -1.9% | +14.5% | +5.5% |
| Profitability & leverage | |||||||
| Net income margin | +6.8% | +5.2% | +4.6% | +4.3% | +2.9% | +7.0% | +2.7% |
| Return on capital employed | - | +18.3% | +17.1% | +17.4% | +13.5% | +19.4% | +10.9% |
| Return on net worth | - | +19.2% | +17.6% | +19.9% | +13.3% | +25.5% | +10.0% |
| Debt / equity | - | 0.86 | 0.92 | 1.07 | 1.05 | 1.03 | 1.07 |
| Long-term debt / equity | - | 0.24 | 0.24 | 0.27 | 0.30 | 0.30 | 0.24 |
| Interest cover | 23.44 | 26.51 | 34.34 | 24.70 | 36.64 | 18.38 | 48.01 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 2.64 | 2.56 | 2.79 | 2.73 | 2.23 | 2.15 |
| Inventory turnover | - | 8.50 | 7.56 | 7.32 | 7.47 | 6.37 | 6.48 |
| Debtors turnover | - | 4.57 | 4.66 | 5.33 | 5.26 | 4.76 | 4.59 |
| EPS (βΉ) | 10.79 | 7.61 | 5.89 | 5.72 | 3.23 | 10.64 | 3.84 |
| Dividend per share (βΉ) | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 1.10 | 1.00 |
| Book value per share (βΉ) | 0.00 | 43.65 | 36.41 | 31.68 | 26.32 | 45.67 | 39.42 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 367 | 311 | 269 | 267 | 271 | 278 | 256 | 268 |
| Revenue growth (YoY) | +35.6% | +11.7% | +4.8% | -0.4% | +7.1% | - | - | - |
| Other income | 1.44 | 5.82 | 2.31 | 4.76 | 15.56 | 0.42 | 2.26 | 5.26 |
| Total expenses | 315 | 277 | 243 | 233 | 244 | 255 | 227 | 242 |
| EBITDA | 51.83 | 33.96 | 25.74 | 34.13 | 27.36 | 23.58 | 29.20 | 25.99 |
| EBITDA margin | +14.1% | +10.9% | +9.6% | +12.8% | +10.1% | +8.5% | +11.4% | +9.7% |
| Depreciation | 6.14 | 5.65 | 5.27 | 5.10 | 4.96 | 4.06 | 4.25 | 4.20 |
| Interest | 6.09 | 5.53 | 5.68 | 5.92 | 6.06 | 5.56 | 5.51 | 5.41 |
| Profit before tax | 41.04 | 28.60 | 17.10 | 27.87 | 31.90 | 14.38 | 21.70 | 21.64 |
| Tax | 10.41 | 7.82 | 4.24 | 7.25 | 6.42 | 3.39 | 5.38 | 5.51 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,118 | 1,057 | 925 | 922 | 780 | 539 | 472 |
| Revenue growth | +5.8% | +14.2% | +0.3% | +18.2% | +44.7% | +14.2% | - |
| Other income | 28.45 | 14.86 | 15.05 | 3.63 | 10.28 | 7.11 | 6.39 |
| Total expenses | 997 | 951 | 844 | 839 | 728 | 483 | 430 |
| Employee cost | 0.00 | 44.53 | 36.44 | 31.83 | 26.97 | 23.45 | 23.40 |
| EBITDA | 121 | 105 | 81.18 | 83.13 | 52.59 | 56.08 | 42.36 |
| EBITDA margin | +10.8% | +10.0% | +8.8% | +9.0% | +6.7% | +10.4% | +9.0% |
| Depreciation | 20.97 | 16.57 | 14.99 | 17.12 | 13.96 | 11.06 | 19.43 |
| Interest | 23.19 | 21.70 | 21.70 | 17.01 | 13.73 | 9.06 | 10.65 |
| Profit before tax | 105 | 81.88 | 59.54 | 52.63 | 35.18 | 43.07 | 18.67 |
| Tax | 25.72 | 20.48 | 15.04 | 14.61 | 10.27 | 10.09 | 4.89 |
| Net profit | 79.77 | 61.41 | 42.80 | 38.00 | 24.87 | 32.80 | 13.77 |
| Net profit margin | +7.1% | +5.8% | +4.6% | +4.1% | +3.2% | +6.1% | +2.9% |
| EPS (βΉ) | 10.85 | 8.46 | 6.13 | 5.37 | 3.52 | 9.33 | 4.14 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 36.29 | 36.29 | 36.29 | 35.35 | 35.35 | 35.35 | 33.35 |
| Reserves & surplus | 354 | 279 | 221 | 182 | 148 | 125 | 97.10 |
| Shareholders' funds (net worth) | 390 | 315 | 258 | 217 | 183 | 161 | 132 |
| Secured loans | 300 | 278 | 212 | 230 | 206 | 156 | 142 |
| Unsecured loans | 5.86 | 1.85 | 0.01 | 0.00 | 0.00 | 2.93 | 0.00 |
| Total debt | 306 | 280 | 212 | 230 | 206 | 158 | 142 |
| Total liabilities | 699 | 599 | 471 | 449 | 391 | 320 | 277 |
| Assets | |||||||
| Gross block | 503 | 428 | 377 | 352 | 322 | 251 | 232 |
| Net block | 315 | 257 | 203 | 194 | 180 | 123 | 115 |
| Capital work in progress | 29.98 | 32.27 | 19.30 | 17.54 | 19.67 | 53.70 | 23.73 |
| Investments | 5.40 | 5.59 | 5.06 | 3.07 | 2.81 | 2.81 | 1.13 |
| Inventories | 152 | 119 | 99.11 | 114 | 98.01 | 77.21 | 76.10 |
| Sundry debtors | 307 | 276 | 222 | 202 | 185 | 133 | 107 |
| Cash & bank balances | 16.16 | 12.25 | 14.62 | 13.23 | 18.92 | 11.12 | 5.34 |
| Loans & advances | 38.94 | 44.91 | 45.31 | 32.81 | 24.69 | 31.37 | 27.17 |
| Total current assets | 514 | 452 | 381 | 362 | 327 | 253 | 216 |
| Total current liabilities | 166 | 155 | 140 | 132 | 146 | 121 | 88.29 |
| Net working capital | 347 | 297 | 242 | 231 | 180 | 132 | 128 |
| Total assets | 699 | 599 | 471 | 449 | 391 | 320 | 277 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 12.25 | 14.62 | 13.49 | 18.92 | 11.12 | 5.34 | 6.54 |
| Net cash from operating activities | 73.13 | 38.63 | 69.46 | 19.17 | (7.43) | 53.27 | 37.48 |
| Net cash from investing activities | (68.50) | (83.92) | (24.59) | (28.06) | (36.17) | (49.89) | (35.04) |
| Net cash from financing activities | (0.72) | 42.91 | (43.74) | 3.20 | 51.40 | 2.40 | (3.65) |
| Net change in cash | 3.91 | (2.37) | 1.13 | (5.68) | 7.80 | 5.78 | (1.20) |
| Closing cash | 16.16 | 12.25 | 14.62 | 13.23 | 18.92 | 11.12 | 5.34 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +5.8% | +14.2% | +0.3% | +18.2% | +44.7% | +14.2% | - |
| EBITDA growth | +15.1% | +29.7% | -2.4% | +58.1% | -6.2% | +32.4% | - |
| PBT growth | +28.8% | +37.5% | +13.1% | +49.6% | -18.3% | +130.7% | -48.7% |
| Net income growth | +29.9% | +43.5% | +12.6% | +52.8% | -24.2% | +138.2% | - |
| Revenue CAGR (3Y) | +6.6% | +10.6% | +19.7% | +25.0% | +14.0% | +15.8% | +19.4% |
| EBITDA CAGR (3Y) | +13.4% | +26.0% | +13.1% | +25.2% | -0.6% | +13.1% | +7.6% |
| Profitability & leverage | |||||||
| Net income margin | +7.1% | +5.8% | +4.8% | +4.1% | +3.2% | +6.1% | +2.9% |
| Return on capital employed | - | +19.4% | +17.7% | +16.6% | +13.8% | +17.5% | +11.1% |
| Return on net worth | - | +21.5% | +18.8% | +19.1% | +14.6% | +22.7% | +10.9% |
| Debt / equity | - | 0.86 | 0.93 | 1.10 | 1.07 | 1.03 | 1.08 |
| Long-term debt / equity | - | 0.23 | 0.24 | 0.27 | 0.30 | 0.30 | 0.24 |
| Interest cover | 23.14 | 24.46 | 32.78 | 25.77 | 35.54 | 20.12 | 46.45 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 2.63 | 2.54 | 2.75 | 2.74 | 2.25 | 2.13 |
| Inventory turnover | - | 9.68 | 8.68 | 8.69 | 8.91 | 7.04 | 6.83 |
| Debtors turnover | - | 4.24 | 4.36 | 4.76 | 4.90 | 4.49 | 4.21 |
| EPS (βΉ) | 10.85 | 8.46 | 6.13 | 5.37 | 3.52 | 9.33 | 4.14 |
| Dividend per share (βΉ) | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 1.10 | 1.00 |
| Book value per share (βΉ) | 0.00 | 43.42 | 35.45 | 30.54 | 25.69 | 45.08 | 38.70 |
Investments & Acquisitions by Indo Amines
Indo Amines has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Key Organics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Crop protection emulsifiers and polymer additives are manufactured. | keyorganics.in | Mumbai, India | 1989 | Oct 2013 | $69.92M |
Complete acquisition details for Indo Amines
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Indo Amines
3 dated milestones of Indo Amines across 28 years, from founding to its latest funding, stage changes and deals.
- Founded Indo Amines is founded.
- Acquisition Acquires Key Organics.
- IPO Lists on the stock exchange (IPO).
Web traffic of Indo Amines
The website of Indo Amines (indoaminesltd.com) receives about 2.4K visits a month.
- Monthly visits2.4K
▼ 26.2% vs previous month
Websites whose visitors overlap most with Indo Amines. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| scientificfertiliser.com | 100% | View details | |||
| alkylamines.com | 100% | 10.6K | #2,201,718 | View details | |
| amines.com | 100% | 4.1K | #4,568,844 | View details | |
| balajiamines.com | 100% | 3K | #6,020,754 | View details | |
| godeepak.com | 99% | 17K | #977,649 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 8 similar websites and full traffic analytics for Indo Amines
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Chemical Preservatives & Ingredients
3 companies that operate in the same segment as Indo Amines (Chemical Preservatives & Ingredients) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of aroma and fragrance chemicals | 1992 | Mumbai, Maharashtra, India | USD 18.56 M | USD 272.53 M | 281 | |
Manufacturer of aroma chemicals and esters | 1988 | Mumbai, Maharashtra, India | USD 12.3 M | USD 303.51 M | 509 | |
Pine chemicals, synthetic resins, and camphor products are manufactured. | 1996 | Mumbai, Maharashtra, India | USD 64.8 M | 248 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Indo Amines
Complete news archive for Indo Amines
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Indo Amines
Indo Amines was founded in 1994.
Indo Amines is headquartered in Thane, India. It is registered at Thane, Maharashtra, India.
Vijay Palkar is the CEO of Indo Amines, as recorded in our data.
Indo Amines has 609 employees.
The primary company behind Indo Amines, Indo Amines Limited, reported revenue of βΉ1,188 Cr for FY 2026, up 8% year on year.
Indo Amines was established in 1994 in Thane, India, within the chemical sector. Aliphatic and aromatic amines are produced by the company as its primary operations. Focus is placed on manufacturing these compounds for various industrial applications. Leadership is provided by CEO and MD Vijay Palkar. Activities are centered in India, supporting the specialty chemicals domain through consistent production processes.
Indo Amines offers Fine Chemicals and Specialty Chemicals.
Yes, Indo Amines is publicly traded on NSE under the ticker symbol INDOAMIN.
Indo Amines has made 1 acquisition, including Key Organics.
Indo Amines operates through Indo Amines Limited.
The legal entities of Indo Amines currently have 18 directors, including Rahul Sharad Chitnis, Suniti Sagar Thombre, Satish Madhukar Chitale and others.
